TABLE 1.
Characteristics of the patients with T2DM before stem cell transplantation
| Characteristic | IV group (n = 15) | DPA group (n = 15) | All |
|---|---|---|---|
| Age, median (interpercentile range), years | 62.0 (57.0‐66.0) | 57.0 (55.0‐61.0) | 59.5 (34‐68) |
| Gender, M:F | 10:05 | 11:04 | 21:09 |
| Duration of T2DM, n (%) | |||
| ≤10 years | 6 (40) | 8 (53.3) | 14 (46.7) |
| >10 years | 9 (60) | 7 (46.7) | 16 (53.3) |
| BMI, n (%) | |||
| <23 kg/m2 | 5 (33.3) | 7 (46.7) | 12 (40) |
| >23 kg/m2 | 10 (66.7) | 8 (53.3) | 18 (60) |
| HbA1c, median (interpercentile range), % | 8.3 (8.0‐9.1) | 7.9 (7.4‐8.6) | 8.2 (7.8‐8.9) |
| FBG, mean ± SD, mmol/L | 9.0 ± 2.4 | 8.2 ± 2.2 | 8.6 ± 2.3 |
| C‐peptide, median (interpercentile range), ng/mL | 1.9 (1.0‐3.0) | 1.4 (0.7‐2.0) | 1.6 (0.97‐2.21) |
Abbreviations: BMI, body mass index; DPA, dorsal pancreatic artery infusion; F, female; FBG, fasting blood glucose; HbA1c, hemoglobin A1c; IV, intravenous infusion; M, male; T2DM, type 2 diabetes mellitus.